Phase III
|
RTOG-0522
|
Cetuximab
|
Active
|
Concurrent chemoRT +/- C225
|
Phase II
|
ECOG-E3303
|
Cetuximab
|
Active
|
Concurrent chemoRT + C225, followed C225 maintenance
|
Phase II
|
RTOG-0234
|
Cetuximab
|
Active
|
Surgery followed by adjuvant chemoRT (cisplatin vs. docetaxel) + C225
|
Phase II
|
NCT00140556
|
Erlotinib
|
Active
|
Concurrent chemoRT + erlotinib + bevacizumab
|
Phase II
|
NCT00226239
|
Cetuximab
|
Active
|
Induction chemotherapy with docetaxel/cisplatin + C225 followed by RT/cisplatin + C225
|
Phase II
|
NCT00193284
|
Gefitinib
|
Active
|
Induction chemotherapy with docetaxel/carboplatin/5-FU + gefitinib followed by RT/gefitinib +/- docetaxel
|